Given the role of PI(3)P in Rab11a activation, and the evidence showing the effect of Rab11a and its effector Rab11fip3 in cancer cell motility [65], we cannot exclude an hidden oncogenic potential in PIK3C2A kinase activity. The gene discussed is PIK3C2A; the disease is cancer.